Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allogeneic Stem Cell Transplant: early-phase trial registry
2 of 3 indexed Allogeneic Stem Cell Transplant trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Allogeneic Stem Cell Transplant: 3 US clinical trials tracked, 2 recruiting.
Allogeneic Stem Cell Transplant is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Michigan Rogel Cancer Center, running 1 of these trials.
Enrollment posture brief
Registry condition allogeneic-stem-cell-transplant
OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Allogeneic Stem Cell Transplant lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Allogeneic Stem Cell Transplant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Allogeneic Stem Cell Transplant is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Donor-Derived Viral Specific T-cells (VSTs)
Children's Hospital Medical Center, Cincinnati
NCT02048332
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
University of Michigan Rogel Cancer Center
NCT06784336
Psychosocial Mobile App for Chronic Graft-Versus-Host Disease
Massachusetts General Hospital
NCT05690971
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Allogeneic Stem Cell Transplant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Allogeneic Stem Cell Transplant trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Allogeneic Stem Cell Transplant page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Allogeneic Stem Cell Transplant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Michigan Rogel Cancer Center sponsors the most Allogeneic Stem Cell Transplant trials on record, review their full trial history before evaluating a specific study. See University of Michigan Rogel Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Allogeneic Stem Cell Transplant condition card totals 3 registered trials; most-linked intervention App; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.